{"description":"SAE suspected to be related to the study treatment that occurred after the defined reporting period and up to 8 years from treatment start had also to be reported to the Sponsor.","eventGroups":[{"deathsNumAffected":12,"deathsNumAtRisk":54,"description":"All patients who have received at least one dose of treatment will be considered as Safety Population","id":"EG000","otherNumAffected":47,"otherNumAtRisk":54,"seriousNumAffected":19,"seriousNumAtRisk":54,"title":"Safety Population"},{"deathsNumAffected":0,"deathsNumAtRisk":54,"description":"Subjects treated with R-CHOP (CHOP21).","id":"EG001","otherNumAffected":47,"otherNumAtRisk":54,"seriousNumAffected":17,"seriousNumAtRisk":54,"title":"R-CHOP + Lyposomal Cytarabine"},{"deathsNumAffected":0,"deathsNumAtRisk":48,"description":"Subjects treated with HD-MTX.","id":"EG002","otherNumAffected":17,"otherNumAtRisk":48,"seriousNumAffected":3,"seriousNumAtRisk":48,"title":"HD-MTX"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":54,"numEvents":5},{"groupId":"EG001","numAffected":3,"numAtRisk":54,"numEvents":4},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Alopecia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":54,"numEvents":13},{"groupId":"EG001","numAffected":8,"numAtRisk":54,"numEvents":10},{"groupId":"EG002","numAffected":2,"numAtRisk":48,"numEvents":3}],"term":"Anemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":54,"numEvents":4},{"groupId":"EG001","numAffected":3,"numAtRisk":54,"numEvents":4},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Anorexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":54,"numEvents":19},{"groupId":"EG001","numAffected":11,"numAtRisk":54,"numEvents":15},{"groupId":"EG002","numAffected":2,"numAtRisk":48,"numEvents":3}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":54,"numEvents":11},{"groupId":"EG001","numAffected":6,"numAtRisk":54,"numEvents":9},{"groupId":"EG002","numAffected":2,"numAtRisk":48,"numEvents":2}],"term":"Diarreha"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":54,"numEvents":7},{"groupId":"EG001","numAffected":2,"numAtRisk":54,"numEvents":3},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Erythema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":54,"numEvents":20},{"groupId":"EG001","numAffected":8,"numAtRisk":54,"numEvents":16},{"groupId":"EG002","numAffected":4,"numAtRisk":48,"numEvents":4}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":54,"numEvents":4},{"groupId":"EG001","numAffected":4,"numAtRisk":54,"numEvents":4},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":54,"numEvents":17},{"groupId":"EG001","numAffected":9,"numAtRisk":54,"numEvents":14},{"groupId":"EG002","numAffected":3,"numAtRisk":48,"numEvents":3}],"term":"Fever"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":54,"numEvents":4},{"groupId":"EG001","numAffected":2,"numAtRisk":54,"numEvents":2},{"groupId":"EG002","numAffected":1,"numAtRisk":48,"numEvents":1}],"term":"Flue-like Syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":54,"numEvents":20},{"groupId":"EG001","numAffected":14,"numAtRisk":54,"numEvents":19},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":54,"numEvents":21},{"groupId":"EG001","numAffected":6,"numAtRisk":54,"numEvents":17},{"groupId":"EG002","numAffected":3,"numAtRisk":48,"numEvents":3}],"term":"Leukopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":54,"numEvents":7},{"groupId":"EG001","numAffected":3,"numAtRisk":54,"numEvents":3},{"groupId":"EG002","numAffected":4,"numAtRisk":48,"numEvents":4}],"term":"Mucositis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":54,"numEvents":20},{"groupId":"EG001","numAffected":9,"numAtRisk":54,"numEvents":17},{"groupId":"EG002","numAffected":2,"numAtRisk":48,"numEvents":2}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":54,"numEvents":34},{"groupId":"EG001","numAffected":17,"numAtRisk":54,"numEvents":28},{"groupId":"EG002","numAffected":4,"numAtRisk":48,"numEvents":4}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":54,"numEvents":16},{"groupId":"EG001","numAffected":10,"numAtRisk":54,"numEvents":12},{"groupId":"EG002","numAffected":2,"numAtRisk":48,"numEvents":3}],"term":"Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":54,"numEvents":7},{"groupId":"EG001","numAffected":4,"numAtRisk":54,"numEvents":4},{"groupId":"EG002","numAffected":1,"numAtRisk":48,"numEvents":1}],"term":"Paresthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":54,"numEvents":3},{"groupId":"EG001","numAffected":2,"numAtRisk":54,"numEvents":2},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":54,"numEvents":7},{"groupId":"EG001","numAffected":6,"numAtRisk":54,"numEvents":6},{"groupId":"EG002","numAffected":1,"numAtRisk":48,"numEvents":1}],"term":"Sensitive/Peripheral Neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":54,"numEvents":12},{"groupId":"EG001","numAffected":6,"numAtRisk":54,"numEvents":10},{"groupId":"EG002","numAffected":2,"numAtRisk":48,"numEvents":2}],"term":"Transaminases increase"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":54,"numEvents":4},{"groupId":"EG001","numAffected":3,"numAtRisk":54,"numEvents":4},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Trombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":54,"numEvents":5},{"groupId":"EG001","numAffected":3,"numAtRisk":54,"numEvents":5},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Vomiting"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Increase of neutrophilis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Prostatic Cancer"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Thrombosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Atrial fibrillation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Atrial flutter"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Cardiac general pericardial effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Syncope"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"CNS cerebrovascular ischemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":54,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":48,"numEvents":1}],"term":"Intracranial hemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":54,"numEvents":4},{"groupId":"EG001","numAffected":4,"numAtRisk":54,"numEvents":4},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":54,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":48,"numEvents":1}],"term":"Mucositis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Injection site reaction/extravasation changes"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Fever"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Diplopia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Pharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":54,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":48,"numEvents":1}],"term":"Renal failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":54,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Acute urinary retention"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 5.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":54,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":54,"numEvents":2},{"groupId":"EG002","numAffected":0,"numAtRisk":48,"numEvents":0}],"term":"Pneumonia"}],"timeFrame":"All cause mortality was assessed through 5 years after study entry. All AEs were collected from the date of informed consent signature until 30 days after the end of treatment (week 26) for the \"R-CHOP, Depocyte, Methotrexate\" group; from the date of informed consent signature up to week 17 for the 'R-CHOP + Lyposomal Cytarabine' Group; from week 18 until 30 days after the end of treatment (week 26) for the 'HD-MTX' Group"}